Brevan Howard Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-43,380	Closed	-$1.43M	–	1378
2024 Q3	$1.43M	Buy	+43,380	New	+$1.43M	0.01%	292